Shares of GSK PLC GSK advanced 1.98% to £13.68 Tuesday, on what proved to be an all-around positive trading session for the ...

GSK has terminated a phase 1/2 hepatitis B trial after the therapeutic vaccine regimen failed to meet the efficacy endpoint | GSK has terminated a phase 1/2 hepatitis B trial after the therapeutic ...

The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to ...

GSK is part of a global health care company committed to making a positive impact on the health of people around the world.

Duality Biologics ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next-generation antibody-drug conjugate (ADC) therapeutics, today announced that it has ...

GSK has brought its message about the risks of antimicrobial resistance (AMR) to commuters in London. | GSK has brought its ...

Berenberg lowered the firm’s price target on GSK (GSK) to 1,600 GBp from 1,820 GBp and keeps a Buy rating on the shares.Don't Miss our Black ...

Vodafone Group PLC on Wednesday said the former chief financial officer of drugs maker GSK PLC will join its board as a non-executive director. The Berkshire, England-based telecommunications provider ...

Citi said that while it understands these concerns, BAE Systems has similar expected profit growth to US peers, better free ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

Analysts at Berenberg lowered their target price on drugmaker GSK from £18.20 to £16.00 on Monday after hosting chief ...

Shares of GSK PLC GSK inched down 0.41% to £13.35 Friday, on what proved to be an all-around positive trading session for the ...